HNGE
Hinge Health, Inc.
HNGE lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
HNGE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
HNGE's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
HNGE PE Valuation
HNGE has no meaningful PE right now: it lost money over the past year.
HNGE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for HNGE, with profitability improving.
HNGE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.92 | — |
| Q3 2025 | -$11.22 | -$10.43 |
| Q2 2025 | -$11.20 | -$10.20 |
| Q1 2025 | $1.76 | +$3.03 |
HNGE lost $11.22 per share over the past year, a bigger loss than the year before.
HNGE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $235M | +52% |
| Q2 2026 | $212.8M | +53% |
| Q1 2026 | $182.3M | +47% |
| Q4 2025 | $170.7M | +46% |
| Q3 2025 | $154.2M | +53% |
| Q2 2025 | $139.1M | +55% |
| Q1 2025 | $123.8M | +50% |
| Q4 2024 | $117.3M | +44% |
HNGE's revenue has grown year over year every quarter since mid-2024: $235M last quarter, up 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +25 points |
| Q2 2026 | 19% | +436 points |
| Q1 2026 | 18% | +7 points |
| Q4 2025 | 16% | -1.9 points |
| Q3 2025 | -4% | -0.1 points |
| Q2 2025 | -417% | -398 points |
| Q1 2025 | 11% | +49 points |
| Q4 2024 | 18% | +55 points |
HNGE's operating margin was 21% last quarter, up 25 points from the same quarter a year ago, near the top of its range since 2023.
HNGE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $114.2M | +39% |
| Q1 2026 | $43M | +932% |
| Q4 2025 | $63.5M | +70% |
| Q3 2025 | $82.3M | +193% |
| Q1 2025 | $4.2M | +$37.8M |
HNGE generated $322M in free cash flow over the past year, up 112% from the year before.
HNGE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.7% | +3.1M shares |
| 1 year | +97% | +42.6M shares |
| 3 years | +11% | +8.5M shares |
HNGE has 87M diluted shares, up 97% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25.9M |
| Q2 2026 | $26.5M |
| Q1 2026 | $105M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
HNGE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -2.9x | Net Cash |
| Q1 2025 | -15.7x | Net Cash |
HNGE has more cash than debt.
HNGE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.7 | Overbought |
| Stochastic | 87.2 | Overbought |
HNGE's weekly RSI is 79 (overbought) and its Stochastic is 87 (overbought).
HNGE PE vs Healthcare Sector
HNGE has no meaningful PE right now: it lost money over the past year.
HNGE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.2 | 13% above |
| 20 week MA | $94.8 | 28% above |
| 50 week MA | $66.7 | 81% above |
HNGE is in an uptrend: it's above all three of its weekly moving averages, and 81% above its 50-week average.
HNGE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $40.2 | $47.5 | +18% |
| 2026 YTD | $47.5 | $121.0 | +155% |
HNGE has finished every year since 2025 higher, and it's up 155% so far in 2026.